非ステロイド性抗炎症薬の結合部位が脂肪酸アミドヒドロラーゼに結合している
Laura Bertolacci1, Elisa Romeo, Marina Veronesi
1Drug Discovery and Development, Istituto Italiano di Tecnologia, Via Morego 30, 16163 Genoa, Italy.
Journal of the American Chemical Society
|December 18, 2012
まとめ
非ステロイド性抗炎症薬 (NSAIDs) は,エンドカンナビノイドを分解する酵素である脂肪酸アミドヒドロラーゼ (FAAH) をブロックすることができます. この二重作用は,NSAIDとエンドカンナビノイド経路の効果を組み合わせることで,改善された疼痛緩和につながる可能性があります.
科学分野:
- バイオケミストリー バイオケミストリー
- 薬理学 薬理学とは
- 構造生物学 構造生物学とは
背景:
- 非ステロイド性抗炎症薬 (NSAIDs) は,サイクロオキシゲナーゼ (COX) 酵素を阻害し,前立腺ホルモンの生成を減少させます.
- また,一部のNSAIDは,エンドカンナビノイドシグナル伝達に不可欠な酵素である脂肪酸アミドヒドローラゼ (FAAH) とも相互作用する.
- NSAID-FAAHの相互作用の分子基礎を理解することは,新しい鎮痛剤の開発の鍵です.
研究 の 目的:
- NSAID,特にカルプロフェンがFAAHと相互作用する分子メカニズムを解明する.
- 双重FAAH-COX阻害剤の設計の可能性を調査し,鎮痛効果を高める.
主な方法:
- カープロフェンとの複合体におけるFAAHの構造を決定するためのX線結晶学.
- FAAHにおける重要なアミノ酸残留物を調査するためのサイト指向型変異性.
- 酵素活性アッセイはFAAH抑制を定量化するためのものです.
- 分子相互作用を研究するための核磁気共鳴 (NMR) 分析.分子相互作用を研究する.
主要な成果:
- X線構造は,カルプロフェンとFAAHの間の詳細な分子相互作用を明らかにしました.
- ミュタゲネーシスと活性アッセイでは,カルプロフェン結合とFAAH抑制に関与する特定の残基が特定されました.
- NMR分析により,FAAH-カルプロフェン複合体の動態に関するさらなる洞察が得られました.
結論:
- カープロフェンなどのNSAIDはFAAHと結合し,その活動を阻害し,エンドカンナビノイド信号伝達を強化します.
- 構造的および生化学的データは,新しい二重FAAH-COX阻害剤の設計のための基礎を提供します.
- FAAHとCOXの両方の経路をターゲットにすると,優れた疼痛管理戦略が期待されます.
関連する概念動画
Ligand Binding and Linkage
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...
Drug Binding to Blood Components
When drugs enter systemic circulation, they interact with various components of the blood, including proteins such as human serum albumin (HSA), α1-acid glycoprotein (AAG), lipoproteins, globulins, and red blood cells (RBCs).
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are further...
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are further...
Allosteric Proteins-ATCase
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Ligand Binding Sites
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Ligand Binding Sites
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Enzyme Inhibition
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
